Suchergebnisse - "Antineoplastic Agents/adverse effects"
-
1
Autoren:
Quelle: Revue Médicale Suisse. 21:142-146
Schlagwörter: Antineoplastic Agents / administration & dosage, Antineoplastic Agents / adverse effects, Immunoconjugates / administration & dosage, Humans, Neoplasms / drug therapy, Antibodies, Monoclonal / administration & dosage, Immunoconjugates / adverse effects, Antibodies, Monoclonal / therapeutic use
Dateibeschreibung: application/pdf
-
2
Autoren: et al.
Quelle: Liver international, vol. 45, no. 8, pp. e70196
Schlagwörter: Humans, Sunitinib/therapeutic use, Sunitinib/adverse effects, Sunitinib/blood, Male, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/mortality, Cholangiocarcinoma/pathology, Female, Middle Aged, Aged, Bile Duct Neoplasms/drug therapy, Bile Duct Neoplasms/mortality, Bile Duct Neoplasms/pathology, France, Angiogenesis Inhibitors/therapeutic use, Angiogenesis Inhibitors/adverse effects, Progression-Free Survival, Adult, Vascular Endothelial Growth Factor A/blood, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Antineoplastic Agents/adverse effects, Choi criteria, VEGF, angiogenesis inhibitors, biliary tract cancer, tumour density
Dateibeschreibung: application/pdf
-
3
Autoren: et al.
Quelle: Eur J Nucl Med Mol Imaging
Schlagwörter: ddc:610, 03 medical and health sciences, 0302 clinical medicine, Original Article, Antineoplastic Agents/adverse effects [MeSH], Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Glutamate Carboxypeptidase II/adverse effects [MeSH], Glutamate Carboxypeptidase II/therapeutic use [MeSH], Antigens, Surface/therapeutic use [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Radioligand therapy, Positron Emission Tomography Computed Tomography [MeSH], Prostatic Neoplasms, Castration-Resistant/drug therapy [MeSH], Prostate-specific membrane antigen, Antigens, Surface/adverse effects [MeSH], Recombinant Proteins/therapeutic use [MeSH], Therapeutic response, Male [MeSH], Radioisotopes/chemistry [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Salvage Therapy/methods [MeSH], Radiohybrid ligands, Lutetium/chemistry [MeSH], Antineoplastic Agents/chemistry [MeSH], Drug Resistance, Neoplasm [MeSH], Prostate cancer
Dateibeschreibung: application/pdf
-
4
Autoren:
Quelle: Eur J Clin Pharmacol
Schlagwörter: Complementary Therapies, Curcumin, Neoplasms, Weight Loss, Weight Loss/drug effects [MeSH], Complementary and alternative medicine (CAM), Antineoplastic Agents/adverse effects [MeSH], Neoplasms [MeSH], Cancer, Humans [MeSH], Curcumin/therapeutic use [MeSH], Nutritional supplements, Randomized Controlled Trials as Topic [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Review, Complementary Therapies/methods [MeSH], Humans, Antineoplastic Agents, Randomized Controlled Trials as Topic
-
5
Autoren: et al.
Quelle: Cancer Chemother Pharmacol
Cancer Chemotherapy and Pharmacology, 94, 6, pp. 799-806Schlagwörter: Male, Adult, Lung Neoplasms, Nephrology - Radboud University Medical Center, Intensive Care - Radboud University Medical Center, Antineoplastic Agents, Bayes Theorem, Pemetrexed, Enkephalins, Middle Aged, Kidney Function Tests, Kidney, Models, Biological, Kidney/drug effects [MeSH], Antineoplastic Agents/adverse effects [MeSH], Aged [MeSH], Antineoplastic Agents/administration, Bayes Theorem [MeSH], Models, Biological [MeSH], Cystatin C/blood [MeSH], Renal function, Biomarker, Male [MeSH], Creatinine/blood [MeSH], Pemetrexed/pharmacokinetics [MeSH], Female [MeSH], Adult [MeSH], Biomarkers/blood [MeSH], GFR, Kidney/metabolism [MeSH], Humans [MeSH], Protein Precursors/blood [MeSH], Middle Aged [MeSH], Kidney Function Tests/methods [MeSH], Antineoplastic Agents/pharmacokinetics [MeSH], Enkephalins/blood [MeSH], Pharmacokinetics, Pemetrexed/administration, Lung cancer, Chemotherapy, Lung Neoplasms/drug therapy [MeSH], Original Article, Creatinine, Humans, Female, Cystatin C, Protein Precursors, Pulmonary Diseases - Radboud University Medical Center, Biomarkers, Pharmacy, Pharmacology and Toxicology - Radboud University Medical Center, Aged
-
6
Autoren: et al.
Quelle: Trends in Pharmacological Sciences. 45:872-879
Schlagwörter: Peripheral Nervous System Diseases/chemically induced, Peripheral Nervous System Diseases, in vitro, Antineoplastic Agents, Antineoplastic Agents/adverse effects, in vivo, neurofilament light chain, Neurofilament Proteins, neurotoxicity, Neurofilament Proteins/blood, Humans, Animals, clinical studies, Biomarkers/blood, Biomarkers, chemotherapy-induced peripheral neuropathy
-
7
Autoren: et al.
Quelle: Eur Arch Otorhinolaryngol
European Archives of Oto-Rhino-Laryngology, 281, pp. 6627-6635Schlagwörter: Male, Adult, Squamous Cell Carcinoma of Head and Neck, Antineoplastic Agents, Hearing loss, Chemoradiotherapy, Otorhinolaryngology - Radboud University Medical Center - DCMN, Middle Aged, Ototoxicity, Drug Administration Schedule, Head and neck, Head and Neck Neoplasms, Audiometry, Pure-Tone [MeSH], Antineoplastic Agents/adverse effects [MeSH], Aged [MeSH], Antineoplastic Agents/administration, Cisplatin/adverse effects [MeSH], Male [MeSH], Squamous Cell Carcinoma of Head and Neck/therapy [MeSH], Chemoradiotherapy/adverse effects [MeSH], Female [MeSH], Adult [MeSH], Cisplatin/administration, Humans [MeSH], Drug Administration Schedule [MeSH], Head and Neck Neoplasms/therapy [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Hearing Loss/etiology [MeSH], Carcinoma, Squamous Cell/therapy [MeSH], Cisplatin, Head and Neck, Hearing Loss/chemically induced [MeSH], Carcinoma, Squamous Cell, Humans, Audiometry, Pure-Tone, Female, Hearing Loss, Retrospective Studies, Aged
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39242413
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/313581
https://hdl.handle.net/1887/4178477
https://pure.amsterdamumc.nl/en/publications/b08b1ea1-ad24-405e-ac9c-328fc9c265ef
https://doi.org/10.1007/s00405-024-08880-x
https://repository.ubn.ru.nl//bitstream/handle/2066/313581/313581.pdf
https://hdl.handle.net/2066/313581
https://repository.publisso.de/resource/frl:6498177 -
8
Autoren: et al.
Quelle: Ann Hematol
Annals of hematology 103(9), 3429-3442 (2024). doi:10.1007/s00277-024-05851-4Schlagwörter: 03 medical and health sciences, Aniline Compounds, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Nitriles, Quinolines, Humans, Antineoplastic Agents, Review, Protein Kinase Inhibitors, Antineoplastic Agents/adverse effects [MeSH], Aniline Compounds/therapeutic use [MeSH], Nitriles/therapeutic use [MeSH], Quinolines/therapeutic use [MeSH], Adverse event management, Humans [MeSH], Aniline Compounds/adverse effects [MeSH], Quinolines/adverse effects [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Nitriles/adverse effects [MeSH], Dosing strategies, Chronic myeloid leukemia, Antineoplastic Agents/therapeutic use [MeSH], Bosutinib, Quinolines/administration, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy [MeSH], Protein Kinase Inhibitors/adverse effects [MeSH]
-
9
Autoren: et al.
Weitere Verfasser: et al.
Quelle: RETINAL Cases & Brief Reports. 18:455-458
Schlagwörter: Male, Methotrexate/adverse effects, Antimetabolites, Antineoplastic, Skin Neoplasms, Antineoplastic Agents, Antineoplastic Agents/adverse effects, Sciences bio-médicales et agricoles, Vemurafenib/adverse effects, Middle Aged, 3. Good health, Antimetabolites, Antineoplastic/adverse effects, Uveitis, Methotrexate, Vemurafenib, Skin Neoplasms/drug therapy, Intravitreal Injections, Uveitis/chemically induced, Humans, Melanoma/drug therapy, Female, Melanoma
Dateibeschreibung: 1 full-text file(s): application/vnd.openxmlformats-officedocument.wordprocessingml.document
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36977328
https://biblio.vub.ac.be/vubir/intravitreal-methotrexate-in-vemurafenibinduced-uveitis(fb5d477c-19f3-4841-8925-1a317f51f542).html -
10
Autoren: et al.
Weitere Verfasser: et al.
Quelle: J Clin Oncol
Schlagwörter: Cancer Research, [SDV]Life Sciences [q-bio], Hearing Loss / prevention & control, Thiosulfates, Antineoplastic Agents, Thiosulfates / pharmacokinetics, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Humans, Hearing Loss, Child, Review Articles, Antineoplastic Agents / administration & dosage, Hearing Loss / chemically induced, Antineoplastic Agents / adverse effects, Neoplasms / drug therapy, Thiosulfates / administration & dosage, Antineoplastic Agents / therapeutic use, 3. Good health, Oncology, Thiosulfates / therapeutic use, Cisplatin / adverse effects, Cisplatin / therapeutic use, Cisplatin, Cisplatin / administration & dosage, Antineoplastic Agents / pharmacokinetics, Cisplatin / pharmacokinetics
Dateibeschreibung: application/pdf
-
11
Autoren: et al.
Quelle: Future Oncol
Schlagwörter: Male, Adult, Febrile neutropenia, Antineoplastic Agents, Drug interactions, Febrile Neutropenia / chemically induced, Hospitalization / statistics & numerical data, Risk Factors, Neoplasms, Granulocyte Colony-Stimulating Factor / therapeutic use, Granulocyte Colony-Stimulating Factor, Humans, Hospital Mortality, Chemotherapy-Induced Febrile Neutropenia / etiology, Chemotherapy-Induced Febrile Neutropenia, Febrile Neutropenia, Aged, Retrospective Studies, Febrile Neutropenia / etiology, Aged, 80 and over, Antineoplastic Agents / adverse effects, Chemotherapy-Induced Febrile Neutropenia / epidemiology, Neoplasms / drug therapy, Antineoplastic Agents / therapeutic use, Middle Aged, Febrile Neutropenia / epidemiology, Granulocyte-colony stimulating factor, Real-world data, Hospitalization, Female, Neoplasms / complications, Research Article
Dateibeschreibung: application/pdf
-
12
Autoren: et al.
Quelle: Leukemia
Leukemia, 38, 7, pp. 1522-1533Schlagwörter: Male, Adult, Aged, 80 and over, Niacinamide, Fusion Proteins, bcr-abl, Antineoplastic Agents, Tyrosine Kinase Inhibitors, Middle Aged, Article, 3. Good health, Young Adult, Drug Resistance, Neoplasm, Mutation, Leukemia, Myeloid, Chronic-Phase, Humans, Pyrazoles, Female, asciminib, T315I, chronic myeloid leukemia, Protein Kinase Inhibitors, Antineoplastic Agents/adverse effects [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Fusion Proteins, bcr-abl/antagonists, Male [MeSH], Pyrazoles [MeSH], Niacinamide/analogs, 45/77, Fusion Proteins, bcr-abl/genetics [MeSH], 38/23, Drug Resistance, Neoplasm [MeSH], Protein Kinase Inhibitors/adverse effects [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], 692/699/1541/1990/283/1896, Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Tyrosine Kinase Inhibitors [MeSH], 692/700/565/1436/2185, Leukemia, Myeloid, Chronic-Phase/drug therapy [MeSH], Young Adult [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Leukemia, Myeloid, Chronic-Phase/genetics [MeSH], article, Haematology - Radboud University Medical Center, Aged, Follow-Up Studies
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38755421
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/308412
https://pure.amsterdamumc.nl/en/publications/1c284274-2d92-4ee2-bdd6-fce089708f99
https://doi.org/10.1038/s41375-024-02278-8
https://repository.ubn.ru.nl//bitstream/handle/2066/308412/308412.pdf
https://repository.ubn.ru.nl/handle/2066/308412
https://hdl.handle.net/11573/1721599
https://doi.org/10.1038/s41375-024-02278-8
https://repository.publisso.de/resource/frl:6523282 -
13
Autoren:
Quelle: The Lancet Oncology, vol 25, iss 5
Schlagwörter: United States Food and Drug Administration, Antineoplastic Agents / adverse effects, Humans, Antineoplastic Agents, Antineoplastic Agents / therapeutic use, Drug Approval / legislation & jurisprudence, Drug Approval, United States
Dateibeschreibung: application/pdf
-
14
Autoren: et al.
Quelle: Calcif Tissue Int
Schlagwörter: Bone mineral densitometry, Neoplasms / therapy, Fracture risk, Bone and Bones / drug effects, Osteoblast, Antineoplastic Agents / adverse effects, Neoplasms / drug therapy, Bone Density / drug effects, Antineoplastic Agents, Cancer treatment induced bone loss (CTIBL), Review Article, Antineoplastic Agents / therapeutic use, Bone and Bones, Bone and Bones / metabolism, Fractures, Bone, Immunotherapy / methods, Bone Density, Neoplasms, Quality of Life, Osteoclast, Humans, Immunotherapy, Side effects, Immune Checkpoint Inhibitors
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40146323
-
15
Autoren: et al.
Quelle: Girnita, A, Bjerring, P, Grove, G L, Kauppi, S, Andriessen, A, Lynde, C & Stensvold, A 2025, 'NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse Events', Journal of Drugs in Dermatology, vol. 24, no. 3, 88541s3, pp. s3-88541s. https://doi.org/10.36849/JDD.88541
Schlagwörter: Immunotherapy/adverse effects, Skin Diseases/therapy, Skin Care/methods, Drug Eruptions/etiology, Quality of Life, Humans, Neoplasms/therapy, Molecular Targeted Therapy/adverse effects, Antineoplastic Agents/adverse effects, Scandinavian and Nordic Countries, Algorithms, Radiotherapy/adverse effects
-
16
Autoren: et al.
Quelle: Support Care Cancer
Maksten, E F, Mørch, C D, Jakobsen, L H, Kragholm, K H, Blindum, P F, Simonsen, M R, Ejskjaer, N, Dybkær, K, Gregersen, H, Madsen, J, El-Galaly, T C & Severinsen, M T 2025, 'The course of chemotherapy-induced peripheral neuropathy (CIPN) in hematological patients treated with vincristine, bortezomib, or lenalidomide: the NOVIT study', Supportive Care in Cancer, vol. 33, no. 3, 225. https://doi.org/10.1007/s00520-025-09282-3Schlagwörter: Male, Adult, Numbness, Vincristine/adverse effects, Lymphoma, Peripheral Nervous System Diseases/chemically induced, Antineoplastic Agents, Survivorship, Hematologic Neoplasms/drug therapy, Bortezomib, Multiple myeloma, Antineoplastic Combined Chemotherapy Protocols, Lenalidomide/administration & dosage, Tingling, Humans, Longitudinal Studies, Lenalidomide, Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Research, Peripheral Nervous System Diseases, Antineoplastic Agents/adverse effects, Middle Aged, Vincristine, Hematologic Neoplasms, Female, Bortezomib/adverse effects
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40011273
http://www.scopus.com/inward/record.url?scp=85218734211&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/768536239/s00520-025-09282-3.pdf
https://vbn.aau.dk/da/publications/cb37d27b-cd7e-47c8-8b45-e914f34be36e
https://doi.org/10.1007/s00520-025-09282-3
https://portal.findresearcher.sdu.dk/da/publications/bedcb2f2-adb6-4de8-a18b-badf1f136e60
https://doi.org/10.1007/s00520-025-09282-3 -
17
Autoren:
Quelle: Curr Heart Fail Rep
Schlagwörter: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Ischemic Preconditioning, Myocardial, Humans, Animals, Antineoplastic Agents, Remote ischemic conditioning, Topical Collection on Cardio-Oncology, Mitochondria, Antineoplastic Agents/adverse effects [MeSH], Cancer-treatment, Ischemic Preconditioning, Myocardial/methods [MeSH], Humans [MeSH], Cardiotoxicity/prevention, Cardioprotection, Mitochondria, Heart/drug effects [MeSH], Animals [MeSH], Cardiotoxicity, Neoplasms/drug therapy [MeSH], Anthracycline, Review, Mitochondria, Heart
-
18
Autoren: et al.
Quelle: Patient
Schlagwörter: Neoplasm Staging [MeSH], Systematic Review, Female [MeSH], Antineoplastic Agents/adverse effects [MeSH], Patient Preference [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/pathology [MeSH], ddc:610, Humans, Patient Preference, Breast Neoplasms, Female, Antineoplastic Agents, Neoplasm Metastasis, Neoplasm Staging
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38451419
https://repository.publisso.de/resource/frl:6506401
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-397446
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39744
https://doi.org/10.1007/s40271-024-00679-6
https://opus.bibliothek.uni-wuerzburg.de/files/39744/40271_2024_Article_679.pdf -
19
Autoren: et al.
Quelle: Ann Hematol
Schlagwörter: Male, Aged, 80 and over, Sulfonamides, Incidence, Antineoplastic Agents, Middle Aged, Bridged Bicyclo Compounds, Heterocyclic, Antibodies, Monoclonal, Humanized, Leukemia, Lymphocytic, Chronic, B-Cell, 03 medical and health sciences, Antineoplastic Agents/adverse effects [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Bridged Bicyclo Compounds, Heterocyclic/administration, Antibodies, Monoclonal, Humanized/administration, Chronic lymphocytic leukemia, Germany/epidemiology [MeSH], Rituximab/administration, Sulfonamides/adverse effects [MeSH], Original Article, Sulfonamides/therapeutic use [MeSH], Rituximab/therapeutic use [MeSH], Male [MeSH], Bridged Bicyclo Compounds, Heterocyclic/therapeutic use [MeSH], Rituximab/adverse effects [MeSH], Venetoclax, Tumor lysis syndrome, Bridged Bicyclo Compounds, Heterocyclic/adverse effects [MeSH], Female [MeSH], Humans [MeSH], Prospective Studies [MeSH], Real-world evidence, Incidence [MeSH], Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy [MeSH], Middle Aged [MeSH], Sulfonamides/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Antibodies, Monoclonal, Humanized/therapeutic use [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Tumor Lysis Syndrome/etiology [MeSH], Antibodies, Monoclonal, Humanized/adverse effects [MeSH], Austria/epidemiology [MeSH], 0302 clinical medicine, Germany, Austria, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Prospective Studies, Tumor Lysis Syndrome, Rituximab, Aged
-
20
Autoren: et al.
Quelle: Skipper, M T, Birkebæk, N, Jensen, R B, Rank, C U, Tuckuviene, R, Wehner, P S, Lambine, T-L, Hørlyck, A, Schmiegelow, K, Frandsen, T L, Andrés-Jensen, L & Albertsen, B K 2024, ' Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis : A part of the ALL-STAR study ', European Journal of Haematology, vol. 112, no. 6, pp. 944-956 . https://doi.org/10.1111/ejh.14189
Skipper, M T, Birkebæk, N, Jensen, R B, Rank, C U, Tuckuviene, R, Wehner, P S, Lambine, T L, Hørlyck, A, Schmiegelow, K, Frandsen, T L, Andrés-Jensen, L & Albertsen, B K 2024, 'Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis : A part of the ALL-STAR study', European Journal of Haematology, vol. 112, no. 6, pp. 944-956. https://doi.org/10.1111/ejh.14189Schlagwörter: Male, Adult, Adolescent, long-term cancer survivors, Asparaginase/adverse effects, pediatric hematology/oncology, Antineoplastic Agents, acute lymphoblastic leukemia, Pancreas/pathology, chemotherapy, Young Adult, Cancer Survivors, Humans, Asparaginase, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Survivors, Preschool, Child, 10. No inequality, Pancreas, Pancreatitis/diagnosis, 2. Zero hunger, Infant, Antineoplastic Agents/adverse effects, sequelae, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Middle Aged, 3. Good health, Pancreatitis, Child, Preschool, Case-Control Studies, treatment outcome, Female, Follow-Up Studies
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38351310
https://curis.ku.dk/ws/files/391882789/European_J_of_Haematology_2024_Skipper_Pancreas_related_persisting_sequelae_in_ALL_survivors_with_a_history_of.pdf
https://portal.findresearcher.sdu.dk/da/publications/322bb998-4185-4dd0-8079-2f2b0b6280f5
https://doi.org/10.1111/ejh.14189
https://pure.au.dk/portal/en/publications/5b7754c1-61e0-4a77-ac30-c5ecb5db4870
http://www.scopus.com/inward/record.url?scp=85185463825&partnerID=8YFLogxK
https://doi.org/10.1111/ejh.14189
Nájsť tento článok vo Web of Science 
Full Text Finder 
Full Text